<DOC>
	<DOCNO>NCT00134524</DOCNO>
	<brief_summary>This study intend demonstrate exposure high intensity , DC electromagnetic field , supply investigational device know Molecular Magnetic Energizer ( MME ) , create clinically meaningful improvement pain nerve dysfunction foot patient diabetic peripheral neuropathy ( DPN ) .</brief_summary>
	<brief_title>The Effects Magnetic Molecular Energizer ( MME ) Diabetic Peripheral Neuropathy</brief_title>
	<detailed_description>Diabetic peripheral neuropathy ( DPN ) affect 1/2 diabetic , type I II . It contribute limb amputation , cause painful symptom difficult treat . Application high intensity , DC electromagnetic field , supply investigational device Magnetic Molecular Energizer ( MME ) show pilot study participant DPN foot , create significant improvement painful symptom improve measure neurologic function 7 10 participant . This study enroll participant evaluate baseline regard pain level , nerve function quality life . They randomize receive 120 hr exposure either active MME procedure , sham procedure . Following 120 hrs participant receive evaluation pain level , nerve function quality life . These evaluation repeat final time 6 month follow . The participant blind whether receive active sham procedure . The MME procedure consist lay bed foot lie space two large electromagnetic coil , activate , produce DC magnetic field measuring 5000 gauss . The participant lay bed foot magnetic field 8 12 hour day 10 16 day succession . Breaks allow , restraint require . The procedure may do night participant may sleep . Pain assessment do self assessment use rating Visual Analogue Scale . Neurologic function assess Cutaneous Perception Threshold test use Neurometer , commercially available , FDA approve device . Quality life assessment Neuropathy Specific Quality Life Questionnaire .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Subjects diabetic peripheral neuropathy foot associate pain/discomfort . Stable control diabetes hemoglobin A1c level le 9.0 % entry study . Diabetes type I type II accept . Subjects must able read English . Pacemakers , defibrillator , aneurysm clip , cochlear implant , metallic particle eye ferromagnetic metal shrapnel , projectile implant body . Pregnant woman Concurrent neuropathy due diabetes . Unstable cardiac disease uncontrolled blood pressure . Renal failure Active hepatitis History nerve injury low extremity . History spinal surgery total knee arthroplasty Current malignancy Alcoholism History stroke Seizure disorder Current use long act narcotic medication Skin ulceration breakdown low extremity Peripheral vascular disease sufficient cause extremity pain rest .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Magnetics</keyword>
	<keyword>Electromagnetics</keyword>
	<keyword>Diabetic neuropathy</keyword>
	<keyword>Pain</keyword>
</DOC>